# FDA Inspection 1205651 - Medley Pharmaceuticals Limited - May 19, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/medley-pharmaceuticals-limited/38f497cb-2f3a-4131-b18a-d03dc1d9c5f0
Source feed: FDA_Inspections

> FDA Inspection 1205651 for Medley Pharmaceuticals Limited on May 19, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205651
- Company Name: Medley Pharmaceuticals Limited
- Inspection Date: 2023-05-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1154972 - 2018-12-14](https://www.globalkeysolutions.net/records/fda_inspections/medley-pharmaceuticals-limited/4603a164-174b-4a55-ba3e-3ca32c2768bf)
- [FDA Inspection 973541 - 2016-02-19](https://www.globalkeysolutions.net/records/fda_inspections/medley-pharmaceuticals-limited/6feb921b-24d8-4b36-b175-dac4c3c7ea67)

Company: https://www.globalkeysolutions.net/companies/medley-pharmaceuticals-limited/e3271248-7900-4155-a7db-66f64fa0936b

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c